Deep learning integrates histopathology and proteogenomics at a pan-cancer level

Authors:

Abstract
No abstract available
Funding Information
  • Government of South Australia
  • Clinical and Translational Science Institute, Boston University (TL1TR001447)
  • National Cancer Institute (U24CA210972)
  • National Institute of Environmental Health Sciences (75N91019D00024, 75N91020F00029, P30ES017885)
  • National Center for Advancing Translational Sciences (F30CA271622)
  • National Institutes of Health (S21-167, U01CA214114, U01CA214116, U01CA214125, U24CA210954, U24CA210955, U24CA210967, U24CA210979, U24CA210985, U24CA210986, U24CA210993)
  • U.S. Department of Health and Human Services